O
1.17
0.00 (0.00%)
| Penutupan Terdahulu | 1.17 |
| Buka | 1.18 |
| Purata Dagangan (3B) | 229,001 |
| Modal Pasaran | 36,141,856 |
| Harga / Jualan (P/S) | 12.00 |
| Harga / Buku (P/B) | 9.42 |
| Julat 52 Minggu |
| Margin Operasi (TTM) | -677.39% |
| EPS Cair (TTM) | -1.79 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 53.80% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.83% |
| Nisbah Semasa (MRQ) | 3.82 |
| Aliran Tunai Operasi (OCF TTM) | -12.63 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -7.90 M |
| Pulangan Atas Aset (ROA TTM) | -87.77% |
| Pulangan Atas Ekuiti (ROE TTM) | -199.38% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (AU) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | ONCOSIL FPO [OSL] | - | - |
AISkor Stockmoo
1.8
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 5.0 |
| Osilator Teknikal | 4.0 |
| Purata | 1.75 |
|
OncoSil Medical Ltd is a medical device company. It is engaged in the development and commercialization of its product candidate, the OncoSil localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. It operates in one segment. the device development for new medical treatments. Geographically, the company derives its maximum revenue from Europe and the rest from Australia and New Zealand. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 12.22% |
| % Dimiliki oleh Institusi | 32.76% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |